Position in TARS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,318,070
+$23,967 QoQ
Shares Held
52,718
+12.3% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 256 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in TARS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. TARS ranks #73 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in TARS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,318,070 | 52,718 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,294,103 | 46,958 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,854,910 | 47,080 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,359,161 | 56,523 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,335,401 | 57,650 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,654,904 | 51,682 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $2,742,697 | 49,534 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,595,658 | 48,515 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,349,758 | 49,660 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,584,496 | 43,590 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $842,805 | 41,620 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $639,826 | 36,006 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $640,798 | 35,462 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $358,471 | 28,518 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $404,528 | 27,594 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $467,341 | 27,298 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $376,125 | 25,762 | Shares | Sole | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||